

Publisher: Bentham Science Publishers
E-ISSN: 1875-6018|7|3|148-154
ISSN: 1871-5214
Source: Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol.7, Iss.3, 2008-07, pp. : 148-154
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Sevelamer: antiatherogenic and anti-inflammatory properties
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :